Antifungal activity and toxicity studies of flavanones isolated from Tessaria dodoneifolia aerial parts by Soberón, Maria Victoria et al.
Heliyon 6 (2020) e05174Contents lists available at ScienceDirect
Heliyon
journal homepage: www.cell.com/heliyonResearch articleAntifungal activity and toxicity studies of flavanones isolated from Tessaria
dodoneifolia aerial parts
Jose R. Soberon a,b,*, Melina A. Sgariglia a,b, Jose A. Carabajal Torrez a, Franco A. Aguilar a,
Edgardo J.I. Pero e, Diego A. Sampietro a,b, Julia Fernandez de Luco c, Guillermo R. Labadie c,d
a Catedra de Fitoquímica, Instituto de Estudios Farmacologicos “Dr. A.R. Sampietro”, Facultad de Bioquímica, Química y Farmacia, Universidad Nacional de Tucuman,
Ayacucho 471 T4000INI San Miguel de Tucuman; Tucuman; Argentina
b Consejo Nacional de Investigaciones Científicas y Tecnicas (CONICET), Argentina
c Instituto de Química Rosario, UNR, CONICET, Suipacha 531, S2002LRK, Rosario, Argentina
d Facultad de Ciencias Bioquímicas y Farmaceuticas, Universidad Nacional de Rosario, Suipacha 531, S2002LRK, Rosario, Argentina
e Instituto de Biodiversidad Neotropical (IBN), CONICET, Universidad Nacional de Tucuman, Facultad de Ciencias Naturales e Instituto Miguel Lillo, Horco Molle s/n,














Toxicity assays* Corresponding author.
E-mail address: jrsrody@yahoo.com (J.R. Sobero
https://doi.org/10.1016/j.heliyon.2020.e05174
Received 8 July 2019; Received in revised form 4
2405-8440/© 2020 Published by Elsevier Ltd. ThisA B S T R A C T
Tessaria dodoneifolia [Asteraceae] is traditionally employed in Northwestern Argentina for fungal infections
treatment. We report the antifungal activity guided isolation and identification of substances from aerial parts of
this species, both individually and in combination with fluconazole (FLU), against Candida albicans strains. Two
antifungal flavanones were identified as naringenin (NAR) and pinocembrin (PIN). These compounds could
individually inhibit the growth of C. albicans strains. Combinations of NAR and PIN with FLU were synergistic
against the FLU resistant and sensitive C. albicans strains. Genotoxic and cytotoxic evaluations were also per-
formed. NAR, PIN and their combinations with FLU did not have a genotoxic effect on Bacillus subtilis rec strains.
Finally, these compounds did not show cytotoxicity at concentrations below 80 μg/mL.1. Introduction
Human's fungal infections caused by yeasts have increased in the last
decades, generating infections at superficial levels, as skin or oral in-
fections [1], or even at systemic levels [2]. Candida albicans is among the
microbial agents most frequently involved in hospital infections around
the world [3]. This situation, together with the restricted arsenal of
therapeutic antifungal drugs and the continuous increase of resistance
mechanisms, represents a major clinical challenge to the health system.
In emerging countries, fluconazole (FLU) represents the most widely used
antifungal drug [4], nonetheless the fungistatic action of this drug is a
condition that favors the development of resistant strains [5]. Drug
combinations have emerged as an interesting approach to avoid or
minimize the development of resistance. The synergetic effect ofn).
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is an open access article under tcombination therapies could improve the fungicidal activity, reducing at
the same time the development of resistant strains [6]. Researchings
related to antifungal therapies faces the task of discovering new drugs or
associations between existing drugs that achieves antifungal effects [7].
Plants could be employed as sources of compounds that meet those
needs [8]. Some reports on Argentinean Northwestern folk medicine have
suggested various promising plant species traditionally employed as an-
tifungals [9, 10]. Tessaria dodoneifolia (Hook& Arn.) Cabrera [Asteraceae]
is a plant traditionally used as a natural sweetener in food and beverages
in some countries (Paraguay, Argentina, Bolivia) where it is known as
“chilca” [11], due to the sweet taste of a dihydroflavonol derivative
identified as dihydroquercetin-3-acetate [12]. Many authors have re-
ported the traditional use of this plant to treat fungal infections [9, 10, 11,
13], though there are no scientific studies validating those reports. Theber 2020
he CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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extracts, the isolation of active compounds, their chemical structures
determination and the study of inhibitory activity against C. albicans
strains exerted by those compounds (individually and mixed with FLU).
Genotoxic and cytotoxic activities of purified substances were also tested.
2. Material and methods
2.1. Chemicals
HPLC and ACS solvents were from Sintorgan Labs (Buenos Aires,
Argentina); penicillin, streptomycin, Sabouraud dextrose agar (SDA) and
Mueller-Hinton Agar (MH) media from Britania Labs (Buenos Aires,
Argentina); Fluconazole, histopaque 1077, 2H-tetrazolium-2,3-bis(2-
methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl] hydroxide
salt (MTT), menadione, glucose, glutamine, methylene Blue and p-ani-
saldehyde, Na2HPO4 and NaH2PO4 from Sigma-Life Science (Saint Louis,
MO, USA); KCl, Na3PO4 and NaCl from Biopack (Buenos Aires,
Argentina); DMSO, glycerol, Silica Gel 60 (less than 0.063 mm) and
Trypan Blue from Merck (Darmstadt, Hesse, Germany); sephadex LH20
from Amersham Biosciences, Uppsala, Sweden; RPMI 1640 from Micro-
vet Labs (Buenos Aires, Argentina); CHROMagar® Candida from
CHROMagar Microbiology (Paris, France) and silica gel 60 F254 plates
from Macherey-Nagel GmbH & Co. KG (Düren, Germany).
2.2. Strains and media
Candida albicans (ATCC 10231) strain from American Type Culture
Collection and C. albicans 12–99 clinical isolate strain resistant to FLU
[14] were used. The strains were periodically refreshed from permanent
cultures, as stated by the Clinical and Laboratory Standards Institute
(CLSI) [15]. The strains sensibility to FLU was assessed by disk diffusion
assay. CHROMagar® Candida medium was employed to periodically
check viability and purity of cells cultures.
2.3. Plant material
We employed Tessaria dodoneifolia (Hook & Arn) Cabrera [Aster-
aceae] aerial parts. The specimens were from Tucuman, Northwest
Argentinean, collected on August 2017 (latitude -26.228, longitude
-65.255). The plant material was taxonomically classified. The voucher
specimen was placed in the herbarium of Instituto de Estudios Farm-
acologicos – Facultad de Bioquímica, Química y Farmacia – Universidad
Nacional de Tucuman (the number assigned was: IEF-2017-08-004-JRS)
for future references. Plant material was dried in a ventilated chamber in
the shade, pulverized and kept at -20 C into dark glass bottles.
2.4. Extract preparation
Aqueous (Aq) and Ethanolic Extracts (EE) were prepared, according
to the folk uses data. The extracts were obtained as stated in Farmacopea
Argentina VIII Ed. [16], briefly: Aq extracts were obtained after mixing
10 g of vegetable coarse powder with 100 mL boiling water under
agitation (38 cycles/min) for 20 min, afterward the extract was filtered
through a Whatman No.1 filter paper and dried in a Virtis Liter freezer
dryer, SL model (Virtis, Gardiner, NY, USA). The dried material obtained
represented the extracted material (EM). EE was obtained by stirring at
room temperature 10 g of vegetal powder using ethanol (96%) into a
glass flask closed along four days. The extract was filtered as previously
described, and dried under reduced pressure using rotary vacuum
evaporator (Buchi model 011, Buchi Inc., Italy) at 40 C to obtain the EM.
2.5. Activity-guided fractionation of T. dodoneifolia EE
The EE was chosen for antifungal activity-guided fractionation pro-
cedures. Briefly: an ethanol:water solution (2:3 v:v) was added with 6 g2
of dried EE, afterwards a liquid-liquid extraction was carried out through
successive solvent extraction in an increased polarity order with hexane,
dichoromethane and n-butanol, to yield hexanic (HX), dichoromethanic
(CH), n-butanolic (BU) fractions. The fractions were dried in rotary
evaporator (at 38 C) to produce EMs which were recovered in MeOH
and stored at -20 C. CH fraction was chosen for further purification
steps. An aliquot of CH containing three grams of CH fraction was
chromatographed on Silica Gel 60 (210 mL bed volume, particle size
<0.063 mm) using CH2Cl2:MeOHmixtures in an increased polarity order
(9:1, 7:3 and 1:1 v:v) as the mobile phase. The elution was aided with a
compressor (Electrical RS290, Zhongshan city, Guandong, China). The
80 aliquots eluted (5 mL each one) were studied by TLC, grouped into
four groups (G1-G4) taking into account their chemical compositions,
and dried in rotary evaporator (at 38 C). The EMs generated were
recovered in MeOH. TLC experiments and disk diffusion assays were
performed with samples from G1-G4 groups. G1 was selected for the next
purification step. A sample containing 600 mg of EM from G1 was
chromatographed on Sephadex LH 20 (182 mL bed volume) employing
MeOH as solvent. Eighty aliquots (5 mL each one) were collected and
analyzed by TLC, pooled into four groups (L1-L4) considering chemical
profiles, dried in rotary evaporator (at 38 C) to yield the EMs which
were recovered in MeOH.2.6. TLC experiments
Analytical TLC experiments were carried out on samples from EE, HX,
CH, nBu, G1→G4 and L1→L4 on silica gel 60 F254 plates using tolue-
ne:ethyl acetate:formic acid mixture (5:4:1 v:v:v) as mobile phase. Dried
developed plates were observed under visible and UV light (254 and 366
nm, UV Lamp Model UV 5L-58 Mineralight Lamp) prior and after either
p-anisaldehyde⁄sulfuric acid reagent (for phenolics and terpenes detec-
tion) or natural products reagent (for flavonoids detection) staining [17].2.7. HPLC experiments
HPLC methods were carried out with the L3 group. Analytical con-
ditions were performed to define the running conditions on a Gilson
HPLC (Villiers Le Bel, Val d’Oise, France) with an IB-SIL 5 C18 column (5
μm, 250 4.6 mm ID) from Phenomenex (Torrance, CA, USA), a 118 UV-
Vis detector fromGilson and a Rheodyne injector fitted with a 50 μL loop.
A gradient elution was performed with solvent A: 0.5 % (v⁄v) formic acid
in water and solvent B: 0.5% formic acid in water and acetonitrile (15:85
v:v). The gradient was 0%–40% B, 3min; 40%–45%B, 15min; 45%–75%
B, 3 min; 75%–75% B, 14 min and 0% B, 10 min. Compounds were
detected at 254 nm at a flow rate of 1.2 mL min1. HPLC semipreparative
assays employed a Rheodyne injector fitted with a 500 μL loop, a LUNA
PFP column (250  10 mm ID - 5 μm from Phenomenex), a flow rate of
2.6 mL/min, using the mobile phase and detector employed on analytical
HPLC experiments. The collected compounds were first dried and the
dissolved in MeOH for storage. HPLC semipreparative assays repeated as
many times as necessary to obtain enough quantity of compounds for
further assays. Compounds' purity was verified by analytical HPLC.2.8. NMR spectra
Two compounds purified by HPLC (named P7 and P11) were studied
by one-dimensional NMR methods (1H NMR, 13C NMR and 13C DEPT)
and bidimensional NMR methods (1H–1H COSY, 1H–13C HSQC, 1H–13C
HMBC and 1H-NOE). 10 mg of each compound were dissolved in 0.5 mL
of CDOD3 to record NMR spectra. A Bruker Avance instrument (300 MHz
for 1H NMR and 75.14 MHz for 13C NMR) was employed. Topspin soft-
ware (Bruker) employed the solvent's non-deuterated impurities as in-
ternal standards to obtain the δ (ppm) values.
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P7 and P11 were dissolved in ethanol and MeOH respectively to
determine the optical rotations at 589 nm (0.1 dm cell, 25 C) on Horiba
Sepa-300 polarimeter (Horiba Ltd., Kyoto, Japan). The obtained [α]D25
values were compared with data reported previously [18, 19].
2.10. Disk diffusion assay
The antifungal activity of samples (i.e. plant extracts, fractions eluted
and isolated substances) alone and in the presence of FLU (for synergy
tests) were evaluated against C. albicans ATCC 10231 strain by disk
diffusion assay. The experiments were carried out as described by Endo et
al [20]. Briefly, yeast cells at exponential growth phase were collected
from a 24 h culture on SDA, suspended in sterile distilled water until
reach 103 colony forming units (CFU)/mL and afterward homogenously
spread over MH-GMB agar plates surfaces. Synergy assays employed
MH-GMB agar plates added with 6 μg/mL of FLU [20], referred to as
“þFLU”. One hundredmicrograms of samples were added on paper disks,
and ten placed over agar plate surfaces. The growth inhibition halos were
determined after incubation at 35 C for 24 h. Experiments were per-
formed at least three times.
2.11. Broth microdilution and cell viability assays
Microtiter 96 well plates were employed for growth microdilution
assays as stated by CLSI [15] using RPMI-1640 (with glutamine, without
bicarbonate) with 0.2 % Glucose. Both C. albicans strains previously
described were used. Experiments were carried out with FLU, P7 and
P11. Stock solutions of FLU, P7 and P11 were prepared in DMSO at a
concentration of 1 mg/mL, and then serially diluted in sterile water. The
final concentration of DMSO in the dilutions did not exceed 1%. FLU
concentrations ranged from 0.125 to 32 μg/mL for experiments against
C. albicans FLU sensible strain, and from 0.5 to 128 μg/mL for experi-
ments against FLU resistant strain. P7 and P11 concentrations ranged
from 1.25 to 80 μg/mL. The inoculum was adjusted to 103 CFU/mL in
each well. Plates were incubated at 35 C and the results were visually
read after 48 h. Minimum inhibitory concentration (MIC) was stated as
the minimum FLU concentration which caused 50% decrease in optical
density (MIC-2) or 100% decrease in optical density for isolated com-
pound (MIC-0 or optically clear wells). Optical densities were also
recorded at 530 nm using a Bio-Rad 550 microplate reader (Bio-Rad
Laboratories, CA, USA), according to EUCAST guidelines [21]. Cell
viability assays were carried out as described elsewhere [8]. Briefly: 25
μL aliquots taken from each well were washed, diluted, plated onto SD
agar plates and incubated for 48 h at 35 C to count CFUs. Experiments
were performed at least three times.
2.12. Checkerboard assays
The interactions between FLU þ P7 or P11 against both C. albicans
cells were evaluated employing checkerboard assays on microtiter plates
as stated elsewhere [22]. Briefly, columns 3–11 of the “A” rowwells were
added with FLU. Column 12 (rows B–H) were added with either P7 or
P11. The final concentrations of FLU, P7 and P11 were adjusted at the
same values previously described. Column 1 was the growth control (i.e.
growth medium þ yeast strain) and column 2 was the sterility control
(i.e. growth medium). The remaining wells contained a single combi-
nation of FLU and the compound under assay. All the wells (except ste-
rility controls) were added with exponential growing C. albicans cells
(suspended in RPMI 1640 medium) to obtain 103 CFU/mL as final con-
centration. All the wells were adjusted to 200 μL final volume. The plates
were covered and incubated at 35 C for 48 h [23]. CFU values were
obtained through cell viability assays as previously described. A reduc-
tion in CFU/mL  2 log units exerted by the combination over the most
active agent alone (i.e. the 2-log units criteria) was employed for3
determining the synergism of a combination [24]. Fractional Inhibitory
Concentration (FIC) of each compound was calculated as the ratio be-
tween MIC of the compound in the combined experiments and the MIC of
the same compound individually. The interactions between FLU and the
isolated compounds were assessed through Fractional Inhibitory Con-
centration Index (FICI), i.e. the sum of FICs. FICI data interpretations
were classified in three categories, according to Odds [25]: “synergy”
(FICI 0.5), “antagonism” (FICI >4.0) and “no interaction” (FICI
>0.5–4.0). The MIC values for FLU (alone) which were >4 μg/mL
experimentally (against C. albicans ATCC 10231) and >128 μg/mL
experimentally (against C. albicans 12–99), were considered to be 8
μg/mL and 256 μg/mL respectively (referred to as MIC-0FLU) for calcu-
lation purposes, a criterion reported by other authors [26]. Experiments
were performed at least three times.
2.13. Fungicidal activity assays
Checkerboard assay carried out with 104 CFU/mL inocula [27], fol-
lowed by viable cell count experiments were used to assess the fungicidal
activity of P7 and P11 alone and in combination. To define the >99.9%
cell viability lost of initial inocula the criterion of 3 log units decrease in
CFU/mL compared to the growth control (above the 10 CFU/mL limit of
detection) was employed. The minimal fungicidal concentration (MFC)
was theminimal concentration of a sample which caused>99.9% growth
inhibition. P7 and P11 concentrations ranged from 1.25 to 120 μg/mL,
and the FLU concentrations used were the same as described in check-
erboard assays. Experiments were repeated at least three times with both
C. albicans strains.
2.14. Genotoxic activity
Bacillus subtilis rec assay was employed to assess the genotoxic effects
of isolated compounds. The assay is based on the quantification of the
differences in the growth curves (after Probit transformation) generated
for B. subtilis recþ (DNA repair proficient) and rec- (DNA repair deficient)
strains exposed to samples [28]. Isolated compounds (i.e. P7 and P11)
were evaluated at 0.93–60 μg/mL alone and in combination with FLU: P7
(20 μg/mL) þ FLU (from 0.5-8 μg/mL) and P11 (30 μg/mL) þ FLU (from
0.5-16 μg/mL). S-Probit values obtained were compared with those
described elsewhere [29]. Reference drugs were K2Cr2O7 (genotoxic
agent) and FLU (non-genotoxic agent).
2.15. Cytotoxicity assay
The cytotoxicity of isolated compounds was evaluated by MTT
colorimetric assay on human lymphocytes. Human lymphocytes were
isolated from fresh whole blood from healthy volunteers (25–35 years
old) using Histopaque 1077. Anticoagulated blood (K2EDTA) was diluted
with an equal volume of Ham F10 medium supplemented with gluta-
mine, containing 10 % fetal calf serum (FCS), underlying it with Histo-
paque 1077 (2:1 ratio) and centrifuged at 200 g for 30 min. Mononuclear
cells were separated as a white layer on the top of the Histopaque [30].
Cells were washed with Hank's Salt (HBSS) and centrifuged two times at
200 g for 5 min. Cells were rinsed with PBS, diluted to 5  106 cells/mL,
and cultured in 10 mL Ham F10 supplemented with 10% FCS, 100 IU/mL
of penicillin and 100 ng/mL of streptomycin (complete H–F10 medium)
for 24 h. No adherent peripheral blood lymphocytes (PBL) were sepa-
rated from adherent cells by aspiration, and the number of viable cells
was determined by Trypan blue exclusion test on a hematological counter
(Neubauer Chamber). Harvested lymphocytes were cultured in complete
H–F10 medium (Ham F10 medium added with glutamine, 10 % FCS and
Concanavalin A as mitogen agent), on 5% CO2 atmosphere for 24 h at
37 C. The viable cells number was determined by Trypan blue exclusion
test.
The MTT colorimetric assay was performed as follows: 100 μL ali-
quots of PBL suspension (adjusted up to 105 cells/100 μL) were added
Figure 1. Flow chart of the purification procedure.
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complete H–F10 medium plus lipopolysaccharide (2 μg/mL) and incu-
bated into 5% CO2-air for 24 h at 37 C to obtain the activated cells,
which were washed with PBS buffer, and then incubated for 24 h in
complete H–F10 medium containing the isolated compounds, to give
the final concentrations of 1, 10, 50 and 100 μg/mL. Controls with
DMSO (0.05–0.01 % v/v) were included. After incubation, the exposed
cells were washed with HBSS and each well was added with 10 μL of 5
mg/mL MTT solution (dissolved in H–F10 without FCS), plates were
further incubated in 5% CO2-air 4 h at 37 C. Afterwards, each treat-
ment was centrifuged at 1500 g for 5 min to precipitate cells containing
formazan. The supernatant was removed from each well, and 175 μL of
DMSO was added to dissolve the MTT formazan crystals. The plate was
mixed on a microshaker for 10 min, and read on a microplate reader
(Bio-Rad, California, USA) at 550 nm to attain the OD550 values. Data
were mean values of two experiments performed in triplicate. The
percent viability score (V%) was calculated with the formula: V (%) ¼
(T - S)/(C - S)  100; where T is OD550 value of the cell with samples
after 24 h incubation, C is the OD550 value of the cell without samples
and S is the OD550 value of the cell before sample addition. The con-
centration values of samples that crossed the V (%) were measured as
the inhibitory concentration 50 values (IC50). The IC50 was the con-
centration of a sample necessary to inhibit the growth to 50% of the
control.Table 1. EM and inhibition halos diameter values against C. albicans ATCC 10231 gen
Fraction EM  sd (g) Inhibiti
- FLU
HX 0.81  0.02 6.6  0
CH 2.99  0.10 9.1  0
G1 1.00  0.05 8.8  0
L3 0.332  0.017 8.30 
4
2.16. Trypan blue exclusion test
Aliquots of each experiments including activated lymphocytes plus
samples concentrations and controls were incubated 24 h, tenfold
diluted, stained with 4 % Trypan Blue (TB) in PBS and counted. Mean
values were analyzed and plotted respect to controls.
2.17. Statistical analysis
Data was analyzed by either Student's t-test or one-way ANOVA.
Probability levels below 0.05 (p < 0.05) were considered as statistically
significant.
3. Results and discussion
3.1. Activity-guided fractionation
The extraction yield obtained for Aq was 6.56 and for EE 9.89 g of
EM/100 g of dry plant material. Only EE showed inhibitory halos against
C. albicans by disk diffusion assay, with values of 8.3  1.0 mm (without
FLU) and 12.3  0.5 mm (with FLU). Taking these results into consid-
eration (higher extraction yield and antifungal activity), EE was selected
as raw extract sample for activity-guided purification procedures. The
flow chart of the process is shown in Figure 1. The EM and inhibition
halos diameter values against C. albicans ATCC 10231 generated by
active fractions are showed in Table 1.
The EM and the inhibition halos diameters generated by CH fraction
were higher than those for HX (p < 0.05), while BU did not exhibit
C. albicans ATCC10231 strain growth inhibition (i.e. no inhibition halo
observed). CH was selected for further purification steps.
CH was chromatographed on silica gel to yield only one group (G1)
with antifungal activity against C. albicans ATCC10231 (þFLU and -FLU),
determined by disk diffusion assay, therefore G1 was selected for further
experiments.
G1 was chromatographed on Sephadex LH20 to yield two groups (L2
and L3) with antifungal activity against C. albicans ATCC10231 (þFLU
and -FLU), determined by disk diffusion assay, however L3 yielded EM
and diameters of the inhibition halos significant higher (p < 0.05) than
those for L2 (data not shown). L3 was selected for HPLC experiments.
3.2. Chemical elucidation of the isolated compounds
The L3 group was analyzed through HPLC experiments to yield two
compounds (P7 and P11) with antifungal activities against C. albicans
ATCC 10231. NMR and polarimetric measures allowed the elucidation of
chemical structures, whichwere consistent with flavanones structures, P7:
4’,5,7-trihydroxiflavanone (naringenin) and P11: 5,7-dihydroxiflavanone
(pinocembrin). The spectroscopic data of NMR experiments and polari-
metric assays are showed in Tables 2, 3, and 4. The chemical structures of
naringenin (NAR) and pinocembrin (PIN) are showed in Figure 2.
3.3. Broth microdilution and cell viability assays
Antifungal activities exerted by NAR and PIN against C. albicans
strains (both FLU sensitive and FLU resistant), individually and inerated by active fractions obtained though purification steps of T. dodoneifolia EE.
on halos diameters (mm) against C. albicans ATCC 10231
þFLU
.60 8.0  1.0
.30 13.5  0.50
.20 12.3  0.40
0.60 11.3  0.60
Table 2. 1H and 13C NMR data (δ in ppm) for naringenin (P7) in CD3OD.
Asignation δ13C δ1H mult. (J in Hz)
C2 80.2 5.29 dd (1H, J1 ¼ 12.0; J2 ¼ 3.1 Hz)
C3 43.8 3.06 dd (1H, J1 ¼ 18.0; J2 ¼ 12.3 Hz)
2.68 d (1H, J1 ¼ 18.0)
C4 197.5
C5 165.2
C6 95.8 5.88 d (J ¼ 2.2 Hz)
C7 168.0




C20 128.9 7.28 d (1H, J ¼ 9.9 Hz)a
C30 116.4 6.81 d (1H, J ¼ 8.26 Hz)
C40 158.6
C50 116.4 6.81 d (1H, J ¼ 8.26 Hz)
C60 128.9 7.28 d (1H, J ¼ 9.9 Hz)a
a Deduced from 1H–13C HSQC.
Table 3. 1H and 13C NMR data (δ in ppm) for pinocembrin (P11) in CD3OD.
Asignation δ13C δ 1H mult. (J in Hz)
C2 79.0 5.44 dd (1H, J1 ¼ 12.6; J2 ¼ 3.2 Hz)
C3 42.7 3.07 dd (1H, J1 ¼ 17.0; J2 ¼ 12.8 Hz)
2.76 dd (1H, J1 ¼ 17.0 y J2 ¼ 3.2)
C4 195.9
C5 164.1
C6 95.8 5.92 d (J ¼ 2.2 Hz)
C7 163.2




C20 126.0 7.44 dd (2H, J ¼ 9.9 Hz)a
C30 128.2 7.35 m
C40 128.3 7.35 m
C50 128.2 7.35 m
C60 126.0 7.44 dd (2H, J ¼ 9.9 Hz)a
a Deduced from 1H–13C HSQC.
Table 4. Polarimetric measures obtained for purified compounds.
Compound Name [α]D25 (c, solvent, l)
P7 Naringenin -27.2 (c ¼ 10 mg/mL; CH3CH2OH; l ¼ 100 mm) [18]
P11 Pinocembrin -36.7 (c ¼ 5.9 mg/mL; CH3OH; l ¼ 100 mm) [19]
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and checkerboard assays. The results are showed in Table 5.
The most active isolated substance against both C. albicans strains was
NAR. As showed in Figure 3A, a 2 log units decrease on the viability of
C. albicans ATCC 10231 was obtained from checkerboard assays (initial
inoculum of 103 CFU/mL) followed by viable cell count experiments with
10 μg/mL of NAR, from 6.52 log (experiments carried out with NAR
alone) to 4.43 (experiments carried out with 10 μg NAR/mLþ 0.5 μg FLU/
mL), which suggests that there would be a synergistic combination be-
tween NAR and FLU (FICI ¼ 0.258). These findings differ from those of a
previous report, where NAR did not exert an inhibitory effect against5
C. albicans [31]. The assays carried out with C. albicans 12–99 showed
identical results: there was a reduction in log units count from 7.06 (ex-
periments carried out with 10 μg NAR/mL) to 4.87 (experiments carried
out with 10 μg NAR/mL þ 8 μg FLU/mL - line with squares in Figure 3C),
which suggests that there would be a synergistic combination between
NAR and FLU against C. albicans FLU resistant strain (FICI ¼ 0.188).
PIN showed lower antifungal activity than NAR against both strains,
though our results showed a synergistic effect (FICI ¼ 0.258) for PIN (15
μg/mL) þ FLU (0.5 μg/mL) combination against C. albicans
(ATCC10231) (Figure 3B), results that agree with those reported by [32]
against the same strain. A synergistic effect was also observed for PIN (15
Figure 2. Chemical structures of NAR and PIN.
Table 5. MIC values for NAR and PIN against C. albicans ATCC 10231 and 12–99.
Strain MIC-2 (μg/mL) MIC-0 (μg/mL)
FLU FLU NAR PIN
ATCC 10231 1,00 64.0a 40.0 60.0
12–99 >128 256a 40.0 60.0
a See reference [26] and Section 2.12. for the detailed explanation of these values.
Figure 3. Viable cell count assays with 103 CFU/mL initial inoculums. A) Experiments carried out with NAR against C. albicans ATCC 10231. B) Experiments carried
out with PIN against C. albicans ATCC 10231. C) Experiments carried out with NAR against C. albicans 12–99. D) Experiments carried out with PIN against
C. albicans 12–99.
J.R. Soberon et al. Heliyon 6 (2020) e05174μg/mL) þ FLU (8 μg/mL) combination against C. albicans 12–99 (FICI ¼
0.281) (Figure 3D).
PIN has been described to cause inhibition of trihydroxinaphtalen
reductase, described as a key enzyme on modern fungicidal drugs
development [33]. NAR has been described to cause proton-motive force
alterations in some strains [34], a result which is in agreement with that
obtained by Peng et al. [35], who found some flavanones (PIN included)
affected the energetic homeostasis in pathogenic fungal strains. FLU is
well known to cause alterations on ergosterol biosynthesis pathway [8].
It is accepted that a combination of antimicrobials which act over6
different cell targets may exert a synergistic effect onmicrobial cells [20].
Taking into consideration these reports, our results could match this
statement. White et al. [14] suggested that the FLU resistance observed
for C. albicans 12–99 is sustained on: alterations in the gene that codes for
the ERG11 enzyme and the overexpression of the efflux pump genes
MDR1, CDR1 and CDR2. Our results showed that those FLU resistance
mechanisms did not affect the sensitivity of this yeast to either NAR of
PIN, as each one of these substances showed the same MICs against both
FLU sensitive (ATCC 10231) and FLU resistant (12–99) C. albicans
strains.
Figure 4. Viable cell count assays with 104 CFU/mL initial inoculums. A) Experiments carried out with NAR against C. albicans ATCC 10231. B) Experiments carried
out with PIN against C. albicans ATCC 10231. C) Experiments carried out with NAR against C. albicans 12–99. D) Experiments carried out with PIN against
C. albicans 12–99.
J.R. Soberon et al. Heliyon 6 (2020) e051743.4. Fungicidal activity assays
C. albicans FLU sensitive (ATCC 10231) and FLU resistant (12–99)
strains were employed to assess fungicidal activity (i.e. using 104 CFU/
mL inocula) and cell viability assays of NAR and PIN, both individually
and in combination with FLU. No viable C. albicans FLU sensitive cells
could be recovered from experiments performed with isolated substances
individually (i.e. NAR and PIN), consequently the MFCs were 80 μg/mL
and 120 μg/mL for NAR and PIN respectively. The same MFCs were
obtained for these substances against C. albicans 12–99. No cell growth
was observed for the assays carried out with NAR (20 μg/mL)þ FLU (0.5
μg/mL) and PIN (30 μg/mL)þ FLU (0.5 μg/mL) against C. albicans ATCC
10231 (Figure 4 A and B), suggesting >99.9% of cell viability lost from
initial inoculum. No cell growth could be observed for assays performed
with C. albicans 12–99 carried out with NAR (20 μg/mL) þ FLU (8 μg/
mL) and PIN (30 μg/mL) þ FLU (16 μg/mL) (Figure 4 C and D).
The isolated flavanones are common in plants, however, they have
not been reported in this species before and the folk antifungal activity of
this plant has not been attributed to any specific compound. Even though
up-to-date only PIN antifungal activity against C. albicans has been re-
ported [32], our results show that NAR þ FLU and PIN þ FLU mixtures
are able to exert fungicidal action against the tested strains.
According to Rios & Recio [36], antimicrobial tests should be run
with collection strains, and studies shall include isolated pathogens in the
case of active compounds. We took this into consideration to asses NAR
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claim “positive antimicrobial activity” for isolated compounds that exert
the inhibition in concentrations above 100 μg/mL. Our experiments
showed NAR and PIN exerts inhibitory antifungal activities when assayed
between 60-80 μg/mL (individually) and 15–20 μg/mL in combinatory
assays. NAR showed more antifungal potency than PIN against the
assayed strains, which could be attributed to the hydroxylation on B ring
in the chemical structure of NAR. Rondina et al. [10] described the folk
use of T. dodoneifolia aqueous extract (i.e. infusion) as antifungal, but no
chemical structure or group of chemical constituents were proposed as
responsible for those actions. Our results showed T. dodoneifolia aqueous
extract was not active against the tested strains, instead the ethanolic
extract was the active one. The chemical nature of the antifungal com-
pounds (i.e. flavanones) justifies these findings because of the poor water
solubility exhibited for NAR and PIN, which are readily soluble in
ethanol. NAR and PIN could not be found on T. dodoneifolia aqueous
extract (data not shown).
3.5. Genotoxic activity
B. subtilis rec assay was employed to assess genotoxic activity of NAR,
PIN and combinations of NAR þ FLU and PIN þ FLU. Table 6 shows S-
probit values and results.
No genotoxic effect (i.e.0.123> S-Probit> 0.199) was observed for
PIN, NAR and FLU against B. subtilis rec strains. As NAR and PIN com-
binations with FLU resulted in mixtures with synergistic antifungal ef-








Figure 5. Effects of NAR on the PBL viability (P < 0.05).
J.R. Soberon et al. Heliyon 6 (2020) e05174B. subtilis. NAR þ FLU and PIN þ FLU combinations resulted in non-
genotoxic mixtures, while K2Cr2O7 exhibited a strong genotoxic effect
(S-Probit > 0.593). These findings are in concordance with those previ-
ously reported on rats [12, 37] using T. dodoneifolia extracts. Moreover,
NAR and PIN were recently reported as antigenotoxic molecules, linking
the effect to the inhibition in the formation of pyrimidine cyclobutane
(CPD) [38].3.6. Cell viability
Percent of cell survival was assessed based on metabolic activity and
cell membrane integrity, by the MTT reduction assay and TB staining,
respectively, on PBL cultures. The activated lymphocytes treated with
NAR showed decreased cell viability according to the metabolic activity
observed, and up to 50 μg/mL could be correlated with the effect on
membrane integrity. However, when the NAR concentration increased
from 50 to 100 μg/mL, the metabolic activity showed a tendency toward
loss of viability (greater than that due to DMSO), while the number of
viable cells (according to evaluation of the membrane integrity) was
maintained constant (Figure 5). Matching results were obtained in ex-
periments performed with PIN on activated lymphocytes, where a
decrease in cell viability was observed at the assayed concentrations
(Figure 6), also correlated withmembrane integrity decrease up to 50 μg/
mL. PIN concentrations above 80 μg/mL exhibited a significant loss of
metabolic activity. The number of viable cells (according to evaluation of
the membrane integrity) was maintained constant. From these observa-
tions it could be concluded that concentrations of NAR and PIN lower
than 80 μg/mL presented a 75% viability according to their metabolic
activity level on the cytoxicity assay (considering the sensitivity of acti-
vated lymphocytes).
Others authors assessed the in vitro effect of NAR on cultured human
normal cellsand found NAR possess low cytotoxicity (assessed by
increased intracellular ROS levels). PIN was evaluated previously onFigure 6. Effects of PIN on the PBL viability (P < 0.05).
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cultured cell lines by MTT reduction assay, and showed cytotoxicity on a
variety of cancer and normal cells [39]. Our results showed PIN cyto-
toxicity was identical to that of NAR. Moreover, when the cytotoxicity
exerted by NAR was compared with that of other flavonoids, it could be
observed that the most toxic flavonoids, such as luteolin and quercetin,
share in common the hydroxyl group in position 3 (flavonol) and/or
greater hydroxylation in A ring [40], a chemical structure absent in NAR
and PIN.
4. Conclusion
The activity guided isolation of T. dodoneifolia metabolites allowed
the identification of NAR and PIN as the main antifungal components
with inhibitory activity against C. albicans FLU sensitive (ATCC 10231)
and FLU resistant (12–99) strains. FLU combinations with NAR or PIN
resulted in synergistic effects, with activities over both strains. As far as
we know, this is the first report pointing to NAR and PIN as responsible
compounds for anti-Candida activity of T. dodoneifolia ethanolic extract.
NAR and PIN could only be found on ethanolic fraction, but not in
aqueous extract, which could explain the lack of antifungal activity found
the last one. No genotoxic effects were observed for NAR, PIN and
combinations of these flavanones with FLU. A low cytoxicity exerted by
NAR and PIN at the antifungal MIC give some safety information
regarding the traditional use of T. dodoneifolia as a source of antifungals.
NAR and PIN employed alone and in combination with FLU could
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